Leukemic Optic Nerve Infiltration Responds to Radiation and Blinatumomab

Ophthalmology. 2018 May;125(5):746. doi: 10.1016/j.ophtha.2018.01.024.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Bispecific / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Combined Modality Therapy
  • Humans
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / drug therapy
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / pathology
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / radiotherapy
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / therapy*
  • Leukemic Infiltration / drug therapy
  • Leukemic Infiltration / pathology
  • Leukemic Infiltration / radiotherapy
  • Leukemic Infiltration / therapy*
  • Male
  • Middle Aged
  • Optic Nerve / drug effects*
  • Optic Nerve / pathology
  • Optic Nerve / radiation effects*
  • Radiotherapy*
  • Visual Acuity / physiology

Substances

  • Antibodies, Bispecific
  • Antineoplastic Agents
  • blinatumomab